Invest in the Future of Speech Therapy
Innovative. Scalable. Clinically Proven.
At Theranuvo, we’re transforming the landscape of speech and cognitive therapy through technology that empowers patients, providers, and payers alike. With an aging population, growing demand, and a shortage of licensed therapists, the need for scalable, accessible therapy has never been greater.
Why Now?
A Perfect Storm of Demand, Shortage, and Innovation—The Time is Now.
- 40+ million Americans live with communication or cognitive disorders.
- Only 206,000 licensed SLPs in the U.S. – demand far outpaces supply.
- The $4.59B speech therapy market is projected to nearly double by 2032.
- Increased pressure on healthcare systems to adopt Remote Therapeutic Monitoring (RTM) and digital solutions.
Theranuvo’s Unique Advantage
- Built by SLPs, for SLPs – Clinical credibility and real-world relevance.
- AI-powered automation – Streamlines therapy, documentation, and billing.
- Gamified patient experience – Drives engagement and improves outcomes.
- SLP-powered distribution – Built-in growth engine through therapist referrals.
- HIPAA-compliant cloud backend – Secure, scalable infrastructure.
Market-Proven Strategy
- SLPs receive the platform for free and recommend it to patients.
- RTM-compatible features unlock new billable codes for providers.
- Revenue model based on patient subscriptions and enterprise partnerships.
- Projected to reach 45,000 subscribers and $13.2M in revenue by Year 3.
Our Current Raise
We are currently raising $500,000 in our seed round to complete MVP development and launch commercially by Q3 2025. These funds will accelerate:
- Final software delivery
- Beta program with SLPs and patients
- Regulatory and security enhancements
- Scalable marketing and distribution
Ready For A Pitch?
Join us in shaping the future of digital healthcare. To request our investor deck or schedule a meeting, contact us below.